| Guidelines for the management of thyroid cancer. P Perros, K Boelaert, S Colley, C Evans, RM Evans, G Gerrard Ba, ... Clinical endocrinology 81, 2014 | 1474 | 2014 |
| Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours JK Ramage, AHG Davies, J Ardill, N Bax, M Caplin, A Grossman, ... Gut 54 (suppl 4), iv1-iv16, 2005 | 709 | 2005 |
| Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant … AT Porter, AJB McEwan, JE Powe, R Reid, DG McGowan, H Lukka, ... International Journal of Radiation Oncology* Biology* Physics 25 (5), 805-813, 1993 | 691 | 1993 |
| Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs) JK Ramage, A Ahmed, J Ardill, N Bax, DJ Breen, ME Caplin, P Corrie, ... gut 61 (1), 6-32, 2012 | 688 | 2012 |
| Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project HJ Brisse, MB McCarville, C Granata, KB Krug, SL Wootton-Gorges, ... Radiology 261 (1), 243-257, 2011 | 464 | 2011 |
| A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer PM Quilty, D Kirk, JJ Bolger, DP Dearnaley, VJ Lewington, MD Masone, ... Radiotherapy and Oncology 31 (1), 33-40, 1994 | 452 | 1994 |
| A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone VJ Lewington, AJ McEwan, DM Ackery, RJ Bayly, DH Keeling, ... European Journal of Cancer and Clinical Oncology 27 (8), 954-958, 1991 | 372 | 1991 |
| Gastrinoma (duodenal and pancreatic) RT Jensen, B Niederle, E Mitry, JK Ramage, T Steinmüller, V Lewington, ... Neuroendocrinology 84 (3), 173-182, 2007 | 336 | 2007 |
| Strontium-89 chloride for pain palliation in prostatic skeletal malignancy AH Laing, DM Ackery, RJ Bayly, RB Buchanan, VJ Lewington, ... The British journal of radiology 64 (765), 816-822, 1991 | 324 | 1991 |
| Bone-seeking radionuclides for therapy VJ Lewington Journal of nuclear medicine 46 (1 suppl), 38S-47S, 2005 | 286 | 2005 |
| Criteria for evaluation of disease extent by 123I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force KK Matthay, B Shulkin, R Ladenstein, J Michon, F Giammarile, ... British journal of cancer 102 (9), 1319-1326, 2010 | 243 | 2010 |
| ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Somatostatin Receptor Imaging with 111In-Pentetreotide DJ Kwekkeboom, EP Krenning, K Scheidhauer, V Lewington, R Lebtahi, ... Neuroendocrinology 90 (2), 184-189, 2009 | 186 | 2009 |
| Targeted alpha therapy, an emerging class of cancer agents: a review C Parker, V Lewington, N Shore, C Kratochwil, M Levy, O Lindén, ... JAMA oncology 4 (12), 1765-1772, 2018 | 173 | 2018 |
| The use of 18F-FDG PET/CT in colorectal liver metastases—comparison with CT and liver MRI G Kong, C Jackson, DM Koh, V Lewington, B Sharma, G Brown, ... European journal of nuclear medicine and molecular imaging 35, 1323-1329, 2008 | 170 | 2008 |
| Consensus on molecular imaging and theranostics in neuroendocrine neoplasms V Ambrosini, J Kunikowska, E Baudin, L Bodei, C Bouvier, J Capdevila, ... European journal of cancer 146, 56-73, 2021 | 162 | 2021 |
| Targeted radionuclide therapy for bone metastases VJ Lewington European journal of nuclear medicine 20, 66-74, 1993 | 158 | 1993 |
| Notes for guidance on the clinical administration of radiopharmaceuticals and the use of sealed radioactive sources Health Protection Agency (Great Britain). Administration of Radioactive ... Health Protection Agency, 2006 | 145 | 2006 |
| Cancer therapy using bone-seeking isotopes VJ Lewington Physics in Medicine & Biology 41 (10), 2027, 1996 | 132 | 1996 |
| A phase 1, open-label study of the biodistribution, pharmacokinetics, and dosimetry of 223Ra-dichloride in patients with hormone-refractory prostate cancer and skeletal metastases SJ Chittenden, C Hindorf, CC Parker, VJ Lewington, BE Pratt, B Johnson, ... Journal of Nuclear Medicine 56 (9), 1304-1309, 2015 | 126 | 2015 |
| 18F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra … GJR Cook, C Parker, S Chua, B Johnson, AK Aksnes, VJ Lewington EJNMMI research 1, 1-6, 2011 | 125 | 2011 |
